esomeprazole magnesium is an over-the-counter drug owned by Dexcel Pharma. It was first authorized for market use on October 20, 2020. The drug, available in tablet, orally disintegrating, delayed release;oral dosage forms, contains esomeprazole magnesium as the active ingredient.
The generic version of Esomeprazole Magnesium is expected to be available after December 8, 2036. This is tied to the expiry date of the last patent, which expires on the same date. Therefore, Esomeprazole Magnesium generics will be on the market post this date.
esomeprazole magnesium is a medication used for the treatment of certain stomach and esophagus problems such as acid reflux and ulcers. The effectiveness of esomeprazole magnesium lies in its active ingredient, esomeprazole magnesium, which works by decreasing the amount of acid your stomach makes.
Esomeprazole Magnesium currently holds 2 drug patents, none of which have expired yet. The patent with the last expiry date is US10835488, titled 'Stable orally disintegrating pharmaceutical compositions,' which expires on December 8, 2036. Therefore, Esomeprazole Magnesium generic release can be expected post this data. Below are the details of the patent: